For instance, inhibitors targeting cGAS significantly downregulated IFN expression in TREX1-/- PMBCs in AGS model mice, showing excellent potential for drug development in the treatment of autoimmune diseases caused by DNA accumulation such as AGS and SLE. This evidence concerns the gene IFNA1 and autoimmune disease.